{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:40:35Z","timestamp":1792269635760,"version":"4.4.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"DOI":"10.7759\/cureus.115347","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:28:26Z","timestamp":1787920106000},"source":"Crossref","is-referenced-by-count":1,"title":["Isolated Lip Angioedema Associated With Spironolactone: A Case Report"],"prefix":"10.7759","author":[{"given":"Tawfeeq","family":"Hosein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Nallamothu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini D","family":"Maharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103%2F0019-5049.187776","article-title":"Angioedema: classification, management and emerging therapies for the perioperative physician","volume":"60","author":"Trentman T","year":"2016","unstructured":"Trentman T, Misra L, Khurmi N. Angioedema: classification, management and emerging therapies for the perioperative physician. Indian J Anaesth. 2016, 60:534-41. 10.4103%2F0019-5049.187776","journal-title":"Indian J Anaesth"},{"key":"ref2","article-title":"Angioedema","author":"Memon RJ","year":"2023","unstructured":"Memon RJ, Tiwari V. Angioedema. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref3","article-title":"Spironolactone","author":"Patibandla S","year":"2023","unstructured":"Patibandla S, Heaton J, Kyaw H. Spironolactone. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12932\/AP0556.33.3.2015","article-title":"Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database","volume":"33","author":"Win TS","year":"2015","unstructured":"Win TS, Chaiyakunapruk N, Suwankesawong W, Dilokthornsakul P, Nathisuwan S. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database. Asian Pac J Allergy Immunol. 2015, 33:227-35. 10.12932\/AP0556.33.3.2015","journal-title":"Asian Pac J Allergy Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330659","article-title":"Analyzing real-world adverse events of spironolactone with the FAERS database","volume":"20","author":"Lin G","year":"2025","unstructured":"Lin G, Chen R, Wen C, Li Z, Yan X, Li L. Analyzing real-world adverse events of spironolactone with the FAERS database. PLoS One. 2025, 20:e0330659. 10.1371\/journal.pone.0330659","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310005915","article-title":"Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome","volume":"84","author":"Ghislain PD","year":"2004","unstructured":"Ghislain PD, Bodarwe AD, Vanderdonckt O, Tennstedt D, Marot L, Lachapelle JM. Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome. Acta Derm Venereol. 2004, 84:65-8. 10.1080\/00015550310005915","journal-title":"Acta Derm Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_279_20","article-title":"DRESS syndrome secondary to spironolactone with atypical presentation","volume":"11","author":"Bains A","year":"2020","unstructured":"Bains A, Rajagopal SV, Rao M. DRESS syndrome secondary to spironolactone with atypical presentation. Indian Dermatol Online J. 2020, 11:1022-3. 10.4103\/idoj.IDOJ_279_20","journal-title":"Indian Dermatol Online J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40690","article-title":"Linear IgA bullous dermatosis attributable to the use of spironolactone: a case report","volume":"15","author":"Philip V","year":"2023","unstructured":"Philip V, Ogunleye OO, Chukwu N, Rosenblum I, Collins S. Linear IgA bullous dermatosis attributable to the use of spironolactone: a case report. Cureus. 2023, 15:e40690. 10.7759\/cureus.40690","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/527591-isolated-lip-angioedema-associated-with-spironolactone-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:28:26Z","timestamp":1787920106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/527591-isolated-lip-angioedema-associated-with-spironolactone-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.115347","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}